Syngene International Limited Company Contacts

Syngene International Limited

https://www.syngeneintl.com
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 6000 scientists offer both skills and... Read More
Contacts

Country

India

City

Bengaluru

Headquarters

Bengaluru, Karnataka

Profile

Founded

1993

Industry

Research Services

Size

5001 - 10000

Specialties

Drug Discovery, Drug Development, Drug Manufacturing, Small Molecules, Biologics, Integrated Drug Discovery, Peptides, Oligonucleotides, Antibody Drug Conjugates, PROTACs, Rare and Orphan Drugs, CAR-T, pDNA & mRNA, Central Compound Management, Discovery Chemistry, Discovery Biology, Safety Assessment, Computational & Data Sciences, Chemical Development, Formulation Development, Clinical Development, Analytical Development, Commercial Manufacturing, Sterile Fill-Finish, Molecular Biology, Protein Sciences, Cell Line Development & Analysis, Antibody Generation, Analytical Characterization & Quality Control, Viral Testing & Clearance, Bioanalytical Laboratory Services, Mammalian Gene to GMP

Funding

Total Rounds

2

Last Round

Wed Feb 01 2023

Last Round Series

Post IPO equity

Last Round Raised

$ 145,186,597